Fourth Annual National General Medical Oncology Summit
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 1.25 credits
MOC types
ABS — Accredited CMEUp to 1.25 pointsABIM — Medical KnowledgeUp to 1.25 pointsABS — Self-AssessmentUp to 1.25 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 2 South Biscayne Blvd
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1.25 credits
- MOC · Up to 1.25 points
-
ReleasedApr 30, 2026
-
Last day to claim creditMay 2, 2027 7 months left
-
Research to Practice Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oral SERDs for Breast Cancer | 2026 (Webinar Audio Proceedings)
-
Research to Practice Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Colorectal Cancer | 2026 (Faculty Presentations)
-
Research to Practice Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in ADCs for Breast Cancer | 2026 (Faculty Presentations)
-
Med Learning Group Emerging Oral SERDs in Early HR+/HER2- Breast Cancer: Biomarkers, Shared Decision-Making, and Practical Management of Investigational Therapies
-
Answers in CME Inc. (AiCME) Integrating ESR1m Testing and Novel Oral SERDS Into Multidisciplinary Workflows: Regional Guidance for HR+, HER2- Advanced Breast Cancer
-
Clinical Care Options, LLC (dba Decera Clinical Education) Next-Generation Oral SERDs in Adjuvant ER-Positive/HER2-Negative Early Breast Cancer: Interrogating the Evidence for Clinical Integration
